Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster

被引:5
|
作者
Wagenhauser, Isabell [1 ,2 ]
Reusch, Julia [1 ,2 ]
Gabel, Alexander [1 ]
Krone, Lukas B. [3 ,4 ]
Kurzai, Oliver [5 ,6 ]
Petri, Nils [2 ]
Krone, Manuel [1 ,5 ,7 ]
机构
[1] Univ Hosp Wurzburg, Infect Control & Antimicrobial Stewardship Unit, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Dept Internal Medi 1, Wurzburg, Germany
[3] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England
[4] Univ Bern, Univ Hosp Psychiat & Psychotherapy, Bern, Switzerland
[5] Julius Maximilians Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany
[6] Leibniz Inst Nat Prod Res, Infect Biologye Hans Knoell Inst, Jena, Germany
[7] Univ Hosp Wuerzburg, Infect Control & Antimicrobial Stewardship Unit, Josef-Schneider Str 2-E1, D-97080 Wurzburg, Germany
关键词
D O I
10.1016/j.cmi.2023.01.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:554 / 556
页数:3
相关论文
共 50 条
  • [31] Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination
    Pedersen, Rune M.
    Bang, Line L.
    Madsen, Lone W.
    Sydenham, Thomas V.
    Johansen, Isik S.
    Jensen, Thoger G.
    Justesen, Ulrik S.
    Andersen, Thomas E.
    EMERGING INFECTIOUS DISEASES, 2022, 28 (06) : 1274 - 1275
  • [32] Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron
    Manuela Di Fusco
    Xiaowu Sun
    Mary M. Moran
    Henriette Coetzer
    Joann M. Zamparo
    Mary B. Alvarez
    Laura Puzniak
    Ying P. Tabak
    Joseph C. Cappelleri
    Journal of Patient-Reported Outcomes, 7
  • [33] Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron
    Di Fusco, Manuela
    Sun, Xiaowu
    Moran, Mary M.
    Coetzer, Henriette
    Zamparo, Joann M.
    Alvarez, Mary B.
    Puzniak, Laura
    Tabak, Ying P.
    Cappelleri, Joseph C.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
  • [34] Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy
    Inoue, Sumito
    Igarashi, Akira
    Morikane, Keita
    Hachiya, Osamu
    Watanabe, Masafumi
    Kakehata, Seiji
    Sato, Shinya
    Ueno, Yoshiyuki
    RESPIRATORY INVESTIGATION, 2022, 60 (02) : 248 - 255
  • [35] Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination
    Bauernfeind, Stilla
    Einhauser, Sebastian
    Tydykov, Leonid
    Mader, Anna-Lena
    Salzberger, Bernd
    Hitzenbichler, Florian
    Mohr, Arno
    Burkhardt, Ralph
    Wagner, Ralf
    Peterhoff, David
    VACCINES, 2022, 10 (10)
  • [36] Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report
    Lin, Tzu-Chien
    Fu, Pei-An
    Hsu, Ya-Ting
    Chen, Tsai-Yun
    VACCINES, 2023, 11 (06)
  • [37] Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination
    Fotiadou, Aggeliki
    Tsiptsios, Dimitrios
    Kitmeridou, Sofia
    Mavraki, Eleni
    Iliopoulos, Ioannis
    NEUROLOGICAL SCIENCES, 2023, 44 (02) : 457 - 459
  • [38] BNT162b2 mRNA Covid-19 Vaccine - in a Nationwide Mass Vaccination Setting
    Roest, Stefan
    Hoek, Rogier A. S.
    Manintveld, Olivier C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20): : 1968 - 1970
  • [39] A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination
    King, Eleanor R.
    Towner, Elizabeth
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [40] BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
    Dagan, Noa
    Barda, Noam
    Kepten, Eldad
    Miron, Oren
    Perchik, Shay
    Katz, Mark A.
    Hernan, Miguel A.
    Lipsitch, Marc
    Reis, Ben
    Balicer, Ran D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15): : 1412 - 1423